David E Shapiro

David E Shapiro

UNVERIFIED PROFILE

Are you David E Shapiro?   Register this Author

Register author
David E Shapiro

David E Shapiro

Publications by authors named "David E Shapiro"

Are you David E Shapiro?   Register this Author

37Publications

848Reads

5Profile Views

Darunavir Pharmacokinetics With an Increased Dose During Pregnancy.

J Acquir Immune Defic Syndr 2020 Apr;83(4):373-380

Department of Clinical Pharmacy and Pediatrics, University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000002261DOI Listing
April 2020

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy.

Antimicrob Agents Chemother 2020 Mar 24;64(4). Epub 2020 Mar 24.

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.02260-19DOI Listing
March 2020

Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.

Obstet Gynecol 2018 05;131(5):879-890

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of North Carolina, Chapel Hill, North Carolina; the Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Duke University, Durham, North Carolina; the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; the Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California; and the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000002566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075712PMC
May 2018

Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.

N Engl J Med 2018 04;378(17):1593-1603

From the Departments of Epidemiology (K.R., G.R.S., P.L.W., S.H.-D., K.P.) and Biostatistics (P.L.W., D.E.S.) and the Center for Biostatistics and AIDS Research (Y.H., D.E.S., K.P.), Harvard T.H. Chan School of Public Health, and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (K.R.), Boston; the Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago (E.G.C.); the Department of Medicine and Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (J.S.C., R.M.H.); and the Department of Pediatrics, University of Colorado School of Medicine, Aurora (E.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701666DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984044PMC
April 2018

Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.

AIDS 2017 11;31(18):2465-2474

aDepartment of Biostatistics and Epidemiology, University of Massachusetts-Amherst, Amherst, Massachusetts bDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland cDivision of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia dDivision of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston eDepartment of Immunology and Infectious Diseases, Harvard University, T. H. Chan School of Public Health, Boston, Massachusetts, USA fBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana gUniversity College Institute of Child Health, London, UK hInstitut de recherche pour le développement (IRD) UMI 174-PHPT, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand iDepartment of Biostatistics, Harvard University T. H. Chan School of Public Health, Boston, Massachusetts, USA jVirus Reference Department, National Infection Service, Public Health England, London, UK kDepartment of HIV/AIDS, World Health Organization, Geneva, Switzerland lDepartment of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand and National Institute for Communicable Diseases, Johannesburg, South Africa mSection of Infectious Diseases and International Health, Geisel School of Medicine at Dartmouth, 1 Medical Center Dr, Lebanon, New Hampshire nCenter for Biostatistics in AIDS Research, Harvard University T. H. Chan School of Public Health. Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710822PMC
November 2017

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

N Engl J Med 2016 11;375(18):1726-1737

From the Department of Pathology, Johns Hopkins University School of Medicine (M.G.F.), and the Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health (T.E.T.), Baltimore, and the Division of AIDS, National Institute of Allergy and Infectious Diseases (D.G., K.L.K., R. Browning, L.P.), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (G.K.S.), National Institutes of Health, Bethesda - all in Maryland; the Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston (M.Q., T.F., D.E.S.); the Retrovirology Core Laboratory, University of North Carolina School of Medicine, Chapel Hill (S.A.F., A.J.L.), and FHI 360, Durham (A.S.C.) - both in North Carolina; the UCLA Center for Clinical AIDS Research and Education, Los Angeles (J.S.C.); St. Jude Children's Research Hospital, Memphis, TN (P.M.F.); the Department of Obstetrics and Gynecology, College of Health Sciences, University of Zimbabwe, Harare (T.C.); Anova Health Institute (J.M.), Perinatal HIV Research Unit, University of the Witwatersrand, Faculty of Health Sciences (A.V.), and Empilweni Services and Research Unit (R.S.), Johannesburg, School of Public Health and Family Medicine, University of Cape Town (J.M.), and the Department of Obstetrics and Gynaecology, Stellenbosch University (G.B.T.), Cape Town, and the Centre for the AIDS Programme of Research in South Africa-Umlazi Clinical Research Site (D.M.) and Durban Paediatric HIV (R. Bobat), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban - all in South Africa; the University of North Carolina Project, Kamuzu Central Hospital-Tidziwe Center, Lilongwe, Malawi (F.E.M.); Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda (M.O.); the Department of Obstetrics and Gynecology, B.J. Medical College, Pune, India (R. Bhosale); the Centre for Infectious Disease Research in Zambia, Lusaka, Zambia (B.H.C.); Kilimanjaro Christian Medical Center-Duke University Collaboration, Moshi, Tanzania (P.M.); Frontier Science and Technology Research Foundation, Amherst, NY (M.B.); and the Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1511691DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214343PMC
November 2016

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.

J Acquir Immune Defic Syndr 2016 07;72(3):289-96

*Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA; †Skaggs School of Pharmacy and Pharmaceutical Sciences, Pediatrics Department-Rady Children's Hospital, University of California, San Diego, CA; ‡Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA; §Department of Biostatistics, Harvard School of Public Health, Boston, MA; ‖Department of Medicine, Children's Hospital Boston, Boston, MA; ¶Irmandade da Santa Casa de Misericordia de Porto Alegre, HIV/AIDS Research Department, Porto Alegre, Brazil; #Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; **FHI 360, IMPAACT Operations Office, Durham, NC; ††Program for HIV Prevention and Treatment, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; ‡‡Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, DHHS, Bethesda, MD; §§National Institute of Allergy and Infectious Diseases, Bethesda, MD; and ‖‖Department of Pediatrics, Boston University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911231PMC
July 2016

Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.

AIDS 2015 Jul;29(12):1467-71

aUniversity of Washington bSeattle Children's Research Institute, Seattle, Washington, USA cInstitut de Recherche pour le Développement (IRD) UMI 174-PHPT, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand dHarvard School of Public Health, Boston, Massachusetts eTulane University School of Medicine, New Orleans, Louisiana, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618483PMC
July 2015

Raltegravir pharmacokinetics during pregnancy.

J Acquir Immune Defic Syndr 2014 Dec;67(4):375-81

*Office of the Global AIDS Coordinator, U.S. Department of State, Washington, DC; †Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, CA; ‡Department of Pediatrics and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA; §Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA; ‖Program for HIV Prevention and Treatment (IRD URI 174), Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; ¶Department of Clinical Pharmacy, Drug Research Unit, University of California, San Francisco, San Francisco, CA; #HIV/AIDS Research Department, Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil; **Boston Children's Hospital, Harvard Medical School, Boston, MA; ††Social and Scientific Systems, Inc, Silver Spring, MD; ‡‡Maternal, Adolescent, and Pediatric Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, MD; and §§Department of Pediatrics, Boston University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213295PMC
December 2014

Reduced indinavir exposure during pregnancy.

Br J Clin Pharmacol 2013 Sep;76(3):475-83

Program for HIV Prevention and Treatment (IRD URI 174), Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; Harvard School of Public Health, Boston, MA, USA; Institut de Recherché pour le Développement (IRD), UMI 174-PHPT, Marseille, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bcp.12078
Publisher Site
http://dx.doi.org/10.1111/bcp.12078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769674PMC
September 2013

Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.

J Acquir Immune Defic Syndr 2013 Aug;63(5):593-601

*Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; †Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA; and ‡National Vaccine Program Office/Office of the Assistant Secretary for Health/Office of the Secretary/Department of Health and Human Services, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31829b0b9fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868443PMC
August 2013

Prevalence of HIV among women entering labor who accepted or declined voluntary counseling and testing.

Int J Gynaecol Obstet 2013 Feb 9;120(2):141-3. Epub 2012 Nov 9.

Department of Obstetrics and Gynecology, Faculty of Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijgo.2012.07.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553312PMC
February 2013

Infant outcomes after maternal antiretroviral exposure in resource-limited settings.

Pediatrics 2012 Jun 14;129(6):e1525-32. Epub 2012 May 14.

Department of Pediatrics, Division of Infectious Diseases, David Geffen UCLA School of Medicine, MDCC 22-442, 10833 LeConte Ave, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2011-2340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362906PMC
June 2012

Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.

Pediatr Infect Dis J 2012 Feb;31(2):164-70

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105–3678, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0b013e318235c7aaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261302PMC
February 2012

Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa.

Int J Gynaecol Obstet 2011 Apr 19;113(1):44-9. Epub 2011 Jan 19.

Department of Obstetrics and Gynaecology, Faculty of Health Sciences, Stellenbosch University and Tygerberg Hospital, Stellenbosch, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijgo.2010.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087603PMC
April 2011

Assessing the learning needs of maternal and child health professionals to teach health promotion.

Matern Child Health J 2004 Jun;8(2):87-93

Division of General Pediatrics, Department of Medicine, Children's Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/b:maci.0000025731.88954.4bDOI Listing
June 2004

Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device.

Anesth Analg 2004 Feb;98(2):371-6, table of contents

Pain Trials Center, Brigham & Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1213/01.ane.0000099716.02783.c4DOI Listing
February 2004

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

N Engl J Med 2002 Jun;346(24):1863-70

Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa991159DOI Listing
June 2002